Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox in Obstructive Sleep Apnea Syndrome
NCT02135900Phase 2Completed
- Sponsor
- Northwell Health
- Start
- Dec 2009
- Primary completion
- Apr 2011
- Modality
- GAS (Genetic analysis systems)
- Countries
- 1
01
Overview
A Phase 2 trial of heliox in obstructive sleep apnea syndrome (OSAS), sponsored by Northwell Health. Started Dec 2009; status: completed.
02
Drugs
heliox
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT02135900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135900.